Perfil
Cole Ikkala is currently the Head of Business Operations for the Neuroscience Group at Radius Health, Inc. Prior to this, he worked as the Director of Investor Relations and Communications at NVN Liquidation, Inc.
Cargos activos de Cole Ikkala
| Empresas | Cargo | Inicio |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01/07/2020 |
Antiguos cargos conocidos de Cole Ikkala.
| Empresas | Cargo | Fin |
|---|---|---|
| NVN LIQUIDATION, INC. | Contacto de Relaciones con Inversores | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NVN LIQUIDATION, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Cole Ikkala
